Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Antizol cleared by FDA as first antidote for ethylene glycol poisoning

Dec. 19, 1997

U. of Florida prepares new metal chelators

Dec. 18, 1997

AMPA antagonist investigated for treatment of drug withdrawal

Dec. 9, 1997

FDA clears IND for ImmuLogic's cocaine vaccine

Dec. 5, 1997

Alza and SmithKline Beecham expand Nicoderm marketing agreement

Nov. 19, 1997

New chemical candidate for treating cocaine addiction

Nov. 3, 1997

Spotlight on smoking cessation therapy

Oct. 27, 1997

Nicotrol launched in Austria as OTC

Oct. 24, 1997

FDA clears generic transdermal nicotine product

Oct. 22, 1997

Therapeutic Antibodies and Altana enter alliance for emergency medicine products

Oct. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...